Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, September 02, 2016
Germany-based Vibalogics has expanded its capabilities with a new automatic vial filling line to meet increased demand from biotechnology companies for its specialist live biological manufacturing services for human and veterinary vaccines, gene ...
read more
Monday, November 23, 2020
Vibalogics has initiated Phase I of its planned $150m investment in a late-phase clinical and commercial virotherapy manufacturing facility near Boston, Massachusetts.
read more
Friday, December 11, 2020
Viatris has expanded on the restructuring program announced by Mylan earlier this year.
read more
Cryoport, Inc. and VGXI, Inc., announced a strategic partnership to support biopharmaceutical companies in developing cell and gene therapies and mRNA-based treatments.
read more
VGXI, Inc., a contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines and National Resilience, Inc. (Resilience), a technology-focused biomanufacturing ...
read more
Under a license agreement with the HMRI for development of clinical grade RNA manufacturing services, VGXI announced it has completed all of the partnership’s Phase I initiatives and anticipates Phase II will conclude by 4Q 2019.
read more
Wednesday, December 14, 2016
Vetter has announced that its new clinical syringe line has already manufactured for its customers a double digit number of batches for use in early clinical trials. The line is part of growth expansion activities that have been undertaken at its ...
read more
With the realization of the first successful customer fills, Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has reached another milestone at its new clinical manufacturing facility in Rankweil, Austria.
read more
Vetter, a leading contract development and
manufacturing organization (CDMO), announced today that its new award-winning filling
line at the company’s Ravensburg Vetter South facility is fully validated and ready for
cGMP filling, after successful...
read more
Vetter, a leading global Contract Development and Manufacturing?Organization?(CDMO) has further?invested in additional?capacity to meet this growing global demand in Rankweil, Austria. The site has been modified to the high Vetter quality standards ...
read more
Wednesday, January 19, 2022
Vetter has received the manufacturing authorization for its new site in Rankweil, Austria. As a result of the successful inspection held by the responsible national regulatory authority, the Austrian Agency for Health and Food Safety (AGES), the site...
read more
Thursday, December 04, 2025
Vetter announced the retirement of its Managing Director Thomas Otto after more than 35 years at the company. He will step down at the end of 2025.
read more
Thursday, November 09, 2023
Vetter has been granted a permanent Manufacturer’s Authorization for its clinical development facility located in Rankweil, Austria. This site has been in operation for nearly two years, and the Austrian Agency for Health and Food Safety (AGES), the ...
read more
Wednesday, March 29, 2017
Dr. Claudia Roth, Vice President for Vetter’s department of Innovation Management, has been appointed to the Advisory Board of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA in Stuttgart. Over the next two years, Dr. Roth ...
read more
Vetter and Microdermics announced that they have entered into a strategic cooperation agreement.
read more